Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.

scientific article published on December 2003

Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID14695212

P50authorRishu TakimotoQ123117127
P2093author name stringJunji Kato
Tetsuji Takayama
Yoshiro Niitsu
Minoru Takahashi
Takuya Matsunaga
Koichi Takada
Takeshi Terui
Shinya Minami
Ken Murakami
Tsuzuku Murakami
P433issue24
P407language of work or nameEnglishQ1860
P921main subjectapoptotic processQ14599311
P304page(s)8948-8954
P577publication date2003-12-01
P1433published inCancer ResearchQ326097
P1476titleInduction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors
P478volume63

Reverse relations

cites work (P2860)
Q39248784A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®)).
Q48096055Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis
Q35676767Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis
Q35071254Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage
Q27314528Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen
Q28555059Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells
Q36560030Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein
Q35808910Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma
Q37899223Bugs and drugs: oncolytic virotherapy in combination with chemotherapy
Q37096490Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.
Q41832646Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic/hypoxic insults
Q36637692Current trends in the development and application of molecular technologies for cancer epigenetics
Q37291391DNA damage induced MutS homologue hMSH4 acetylation
Q35861153FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Q34968621Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Q39354874Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases
Q26853102HDAC inhibitors and immunotherapy; a double edged sword?
Q66680337Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus
Q33983255Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights
Q39672349Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression
Q37169993Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms
Q37821337Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
Q41851979Inhibitors of histone deacetylases enhance neurotoxicity of DNA damage
Q34115920Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.
Q27015931Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Q42277637Nicotinamide nucleotide transhydrogenase (NNT) deficiency dysregulates mitochondrial retrograde signaling and impedes proliferation
Q34145992Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells
Q24669960Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?
Q40066192Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
Q36685003Quantitative proteomics analysis of the effects of ionizing radiation in wild type and p53 K317R knock-in mouse thymocytes
Q46262918SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease
Q26749468SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms
Q36956900Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation
Q39429804Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells
Q89169966Targeting Epigenetics in Cancer
Q39113061The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway
Q37676974The emerging role of lysine acetylation of non-nuclear proteins
Q28592663The transcriptional co-activator PCAF regulates cdk2 activity
Q33622581Translocation of p53 to mitochondria is regulated by its lipid binding property to anionic phospholipids and it participates in cell death control
Q24657909p53 acetylation is crucial for its transcription-independent proapoptotic functions

Search more.